title: The trientine crisis in Canada: a call to advocacy.
authors.forename: Natasha
authors.initials: N
authors.lastname: Chandok
authors.forename: Eve A
authors.initials: EA
authors.lastname: Roberts
mesh_terms: D002170:Canada; D002614:Chelating Agents / Q000191:economics* / Q000627:therapeutic use; D003254:Consumer Advocacy; D006527:Hepatolenticular Degeneration / Q000188:drug therapy*; D006801:Humans; D011306:Prescription Fees; D014266:Trientine / Q000191:economics* / Q000627:therapeutic use
chemical_list: D002614:Chelating Agents; D014266:Trientine
references.citation: Hepatology. 2008 Jun;47(6):2089-111
references.pmid: 18506894
references.citation: Q J Med. 1989 Mar;70(263):253-63
references.pmid: 2602537
references.citation: Clin Gastroenterol Hepatol. 2013 Aug;11(8):1028-35.e1-2
references.pmid: 23542331
references.citation: Eur J Neurol. 2014 Apr;21(4):599-606
references.pmid: 24447648
references.citation: N Engl J Med. 1987 Jul 23;317(4):209-13
references.pmid: 3600712
references.citation: N Engl J Med. 2010 Jun 3;362(22):2045-7
references.pmid: 20393164